296 results on '"Cohen, Martin H."'
Search Results
2. Treatment strategies for prostate cancer
3. Gemcitabine and Cisplatin for Advanced, Metastatic Bladder Cancer
4. Thalidomide in the Treatment of High-Grade Gliomas
5. Temozolomide for Advanced, Metastatic Melanoma
6. Phase II study of patients with metastatic nonsmall cell carcinoma of the lung treated with paclitaxel by 3-hour infusion
7. Megestrol for AIDS-Related Anorexia
8. Treatment Strategies for Prostate Cancer.
9. Nocardiosis after corticosteroid therapy for malignant thymoma
10. Vitamin E in the treatment of chemotherapy-induced mucositis
11. Breast cancer risk from diet, tobacco, and alcohol
12. Immunological Studies In Tropical Splenomegaly Syndrome In Uganda
13. Breast cancer: minimalists, maximalists, other neoplasms
14. Cure of advanced L1210 leukemia after correction of abnormal red blood cell deformability
15. Planning for the risk of long term care
16. EFFECTS OF THYMOSIN IN CANCER PATIENTS: IN VITRO AND IN VIVO STUDIES
17. Effects of Thymosin Fraction 5 in Cancer Patients: In Vitro Studies and Correlations with Clinical Course in Patients Receiving Thymosin
18. NITROSOUREA-CONTAINING CHEMOTHERAPY REGIMENS IN THE TREATMENT OF NON-SMALL-CELL LUNG CANCER
19. A proposed student alumni center for the Massachusetts Institute of Technology
20. Approval Summary: Cetuximab in Combination With Cisplatin or Carboplatin and 5-Fluorouracil for the First-Line Treatment of Patients With Recurrent Locoregional or Metastatic Squamous Cell Head and Neck Cancer
21. U.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma
22. FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme
23. Approval Summary: Imatinib Mesylate for One or Three Years in the Adjuvant Treatment of Gastrointestinal Stromal Tumors
24. Approval Summary: Letrozole (Femara® Tablets) for Adjuvant and Extended Adjuvant Postmenopausal Breast Cancer Treatment: Conversion of Accelerated to Full Approval
25. Small-Cell Carcinoma of Lung: Reinduction Therapy After Late Relapse
26. Prospective Staging Evaluation of Patients with Cutaneous T-Cell Lymphomas: Demonstration of a High Frequency of Extracutaneous Dissemination
27. Chemotherapy Alone or Chemotherapy with Chest Radiation Therapy in Limited Stage Small Cell Lung Cancer: A Prospective, Randomized Trial
28. Patients with Small-Cell Lung Cancer Treated with Combination Chemotherapy with or without Irradiation: Data on Potential Cures, Chronic Toxicities, and Late Relapses After a Five- to Eleven-Year Follow-up
29. Risks in Antiemesis Using Dexamethasone
30. Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
31. Approval Summary: Erlotinib Maintenance Therapy of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
32. Approval Summary: Imatinib Mesylate in the Adjuvant Treatment of Malignant Gastrointestinal Stromal Tumors
33. FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
34. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
35. Burkittʼs Tumor
36. Infectious Mononucleosis Followed by Burkittʼs Tumor
37. Pneumocystis carinii Pneumonia
38. FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme
39. Approval Summary: Pemetrexed in the Initial Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
40. FDA Review of a Panitumumab (Vectibix™) Clinical Trial for First-Line Treatment of Metastatic Colorectal Cancer
41. Approval Summary: Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors
42. FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That Overexpresses HER-2
43. FDA Report: Eculizumab (Soliris®) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
44. FDA Drug Approval Summary: Nelarabine (Arranon®) for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma
45. FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
46. FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer
47. FDA Drug Approval Summary: Bevacizumab Plus FOLFOX4 as Second-Line Treatment of Colorectal Cancer
48. Approval Summary: Nelarabine for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma
49. Food and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
50. FDA Drug Approval Summary: Erlotinib (Tarceva®) Tablets
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.